Technical analysis of Quest Diagnostics Incorporated (DGX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing.
Price Performance
| 1 month | +7.49% |
| 3 months | +6.35% |
| Year-to-date | +44.53% |
| 1 year | +40.24% |
| 3 years | +87.30% |
| 5 years | +74.40% |
| 10 years | +208.80% |
52-Week Range
| 52-week High | $256.99 |
| 52-week Low | $171.18 |
| Avg Volume (90d) | 1.0M |
Technical Indicators
| SMA 50 | $238.66 |
| SMA 200 | $212.45 |
| Beta | 0.65 |
| 30-day Volatility (annualised) | 22.9% |
| Price vs SMA 50 | +5.1% |
| Price vs SMA 200 | +18.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $173.53 | |
| 2026-01 | $187.03 | +7.8% |
| 2026-02 | $211.91 | +13.3% |
| 2026-03 | $195.98 | -7.5% |
| 2026-04 | $194.20 | -0.9% |
| 2026-05 | $194.90 | +0.4% |
| 2026-06 | $211.95 | +8.7% |
| 2026-07 | $233.01 | +9.9% |
| 2026-08 | $240.30 | +3.1% |
| 2026-09 | $233.07 | -3.0% |
| 2026-10 | $251.82 | +8.0% |
| 2026-11 | $250.81 | -0.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-10-22 | $2.87 | $3.05B |
| 2026-07-23 | $2.82 | $2.97B |
| 2026-04-21 | $2.37 | $2.83B |
| 2026-02-10 | $2.36 | $2.75B |
| 2025-10-21 | $2.50 | $2.74B |
| 2025-07-22 | $2.57 | $2.73B |
Price
| Price | $250.81 (closing price, November 2, 2026) |
| Market Cap | $27.7B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 24.98 |
| Price / Book | 3.61 |
| Dividend Yield | 1.35% |
Financial Health
| Debt / Equity | 0.82 |
| Current Ratio | 1.70 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 3.17 |